HOME › Research Insight › Detection and Success Rate, Re-excision Rate, Mean Localization Time, and Cost of Localization Devices are the Most Important Factors Influencing the Acceptance Rate of Breast Lesion Localization Methods
Detection and Success Rate, Re-excision Rate, Mean Localization Time, and Cost of Localization Devices are the Most Important Factors Influencing the Acceptance Rate of Breast Lesion Localization Methods
Based on the type of localization devices, the breast lesion localization methods market is segmented into wire localization, radioisotope localization, magnetic tracers, and others. Among these segments, wire localization is the major focus of players as it is an established technique in the market. By 2020, the magnetic tracers segment is expected to grow at the highest CAGR, primarily due to the higher accuracy and use of nonradioactive technology in these devices.
The selection of the appropriate localization method for end users (healthcare providers) is a very crucial decision, and is dependent on a number of factors, such as detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, ease of use, and mean operating time, among other parameters. The importance of these parameters differs according to the diagnostic requirements of various end users.
Detection and success rate, mean localization time, and re-excision rate are perceived to be relatively more important selection criteria by healthcare providers. This is because new localization methods are technologically advanced and offer better features, which have the potential to help healthcare providers deliver improved treatments. However, as a result of budgetary constraints among end users, the cost of localization methods is indicated as one of the most significant criteria for the selection of these instruments.
According to the replacement trends studied in all geographies, wire localization is an established technique for preoperative localization of breast lesions; most respondents are using this technique and are willing to continue with it in the future. However, nearly 40% of healthcare providers are willing to shift towards technologically advanced options such as RSL and magnetic tracers.
Some of the key players in the breast lesion localization methods market are C.R. Bard (U.S.), Ranfac Corporation (U.S.), Invivo Corporation (U.S.), SOMATEX Medical Technologies GmbH (Germany), Argon Medical Devices (U.S.), SurgicEye GmbH (Germany), GE Healthcare (U.K.), Intra-Medical Imaging LLC (U.S.), IsoAid, LLC (U.S.), NuclearLab S.R.L. (Argentina), Cianna Medical (U.S.), Endomagnetics Ltd. (U.K.), and Cook Medical (U.S.), among others.
The key strategies adopted by most companies in this market include new product launches and licensing; agreements, collaborations, and partnerships; and expansion. For instance, in October 2014, IntraMedical Imaging LLC (U.S.) exclusively licensed a patent from the University of South Florida for the use of radioactive localization seeds in breast lesion localization. Similarly, in January 2012, Endomagnetics Ltd. (U.K.) launched Sentimag and Sienna plus, which offers magnetic tracer localization, in the U.K.
Breast Lesion Localization Methods Market - Comparative Analysis, Field Force Analysis, Business Models, End User Preference Survey (Selection Criteria, Qualitative Analysis of Replacement Trend), Competitive Product Portfolio and Strategic Consolidation
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India